Knowledge Culture: Downstream innovation

The cell therapy industry is at a turning point with more and more therapies being developed and approved for clinical and commercial phases. Challenges involve not only developing proof-of-concepts for these life-changing therapies but also making them scalable and safe to benefit more patients. In this workshop, you’ll learn about various solutions, from cell isolation to cell expansion, that can support autologous and allogeneic cell therapy process needs, digital automation, and mycoplasma testing.